HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BMS-955176

a betulin-derived HIV maturation inhibitor

Also Known As:

GSK3532795; benzoic acid, 4-(17-((2-(1,1-dioxido-4-thiomorpholinyl)ethyl)amino)-28-norlupa-2,20(29)-dien-3-yl)-

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Triterpenes: 2493
      - BMS-955176: 1

Experts

1.	Beno, Brett R: 1 article (01/2019)
2.	Cockett, Mark: 1 article (01/2019)
3.	Dicker, Ira: 1 article (01/2019)
4.	Joshi, Samit: 1 article (01/2019)
5.	Krystal, Mark: 1 article (01/2019)
6.	Lataillade, Max: 1 article (01/2019)
7.	Ray, Neelanjana: 1 article (01/2019)
8.	Regueiro-Ren, Alicia: 1 article (01/2019)
9.	Zhang, Sharon: 1 article (01/2019)

Related Diseases

1.	Infections 01/01/2019 - "GSK3532795 (formerly BMS955176) is a second-generation maturation inhibitor (MI) that progressed through a Phase 2b study for treatment of HIV-1 infection. "